NCT05025800 2025-10-09ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin LymphomaM.D. Anderson Cancer CenterPhase 1/2 Active not recruiting47 enrolled